CCL2 and heavy chain disease: Cytokines serve as inflammatory markers, and CCL2, a crucial chemotactic factor for monocytes and macrophages involved in atherosclerotic lesion development, was approximately 60% lower in the HCD + HVK group compared to the HCD group (p < 0.05) (Fig. 4B middle panel).